SCHEMBL9508804

SCHEMBL9508804

CCCCC[C@H]1CC[C@H](c2ccc(C#Cc3ccc(OC)cc3)cc2)CC1

nearest known ligand 0.47

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.47
CYP2C9 P11712 1/20 0.40
APP P05067 2/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
MAPK1 P28482 1/20 0.39
RAB9A P51151 1/20 0.38
SPHK1 Q9NYA1 2/20 0.38
GRM2 Q14416 1/20 0.37
GRM3 Q14832 3/20 0.37
MCHR1 Q99705 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26347319 1.00 DRD2 (0.47) DRD2CYP2C9APPMEN1KMT2A
SCHEMBL9511758 0.99 DRD2 (0.46) DRD2CYP2C9APPMEN1KMT2A
SCHEMBL9509006 0.96 DRD2 (0.48) DRD2CYP2C9APPMEN1KMT2A
SCHEMBL9509338 0.92 DRD2 (0.45) DRD2CYP2C9APPMEN1KMT2A
SCHEMBL7910586 0.92 DRD2 (0.54) DRD2CYP2C9MEN1KMT2AALDH1A1
SCHEMBL7910589 0.92 DRD2 (0.54) DRD2CYP2C9MEN1KMT2AALDH1A1
SCHEMBL9512219 0.91 RAB9A (0.47) CYP2C9LMNARAB9A
SCHEMBL5343187 0.91 DRD2 (0.50) DRD2CYP2C9APPMEN1KMT2A
SCHEMBL13621706 0.91 DRD2 (0.50) DRD2CYP2C9APPMEN1KMT2A
SCHEMBL9744172 0.91 SLC6A2 (0.39) DRD2CYP2C9MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0308438-B1 LIQUID CRYSTAL PHASE CONTAINING TOLANES MERCK PATENT GmbH (DE) 1993-09-29 EP disclosed